The Clinical Correlates of High-Titer IgG Anti-GM1 Antibodies
Ann Neurol 35:234-237, Kornberg,A.J.,et al, 1994
Anti-Ri-Associated Paraneoplastic Neurologic Disorder without Opsoclonus in a Patient with Breast Cancer
Neurol 43:1605-1606, Escudero,D.,et al, 1993
Regression of Small-Cell Lung Carcinoma in Patients with paraneoplastic Neuronal Antibodies
Lancet 341:21-22, Darnell,R.B.&DeAngelis,L.M., 1993
Evolving Toward Effective Therapy for Acute Ischemic Stroke
JAMA 270:360-364, Fisher,M.&Bogousslavsky,J., 1993
Autoantibodies to a 128-kd Synaptic Protein in Three Women with the Stiff-Man Syndrome & Breast Cancer
NEJM 328:546-551, Folli,F.,et al, 1993
Motor Neuron Diseases and Amyotrophic Lateral Sclerosis:GM1 Antibodies and Paraproteinemia
Neurol 43:418-420, Sanders,K.A.,et al, 1993
Paraneoplastic Cerebellar Degener III, Cerebellar Degener, Cancer & Lambert-Eaton Myasthenic Synd
Neurol 42:1944-1950, Clouston,P.D.,et al, 1992
Do NMDA Antagonists Prevent Neuronal Injury? Yes
ARch Neurol 49:418-420, Albers,G.W.,et al, 1992
Do NMDA Antagonists Prevent Neuronal Injury? No
Arch Neurol 49:420-421, Buchan,A.M., 1992
Amyotrophic Lateral Sclerosis and Lymphoma:Bone Marroe Examination and Other Diagnostic Tests
Neurol 42:1101-1102, Rowland,L.P.,et al, 1992
Anti-Hu-Associated Pareneoplastic Encephalomyelitis/Sensory Neuronopathy
Medicine 71:59-72, Dalmau,J.,et al, 1992
Tissue Plasminogen Activator Plus Glutamate Antagonist Improves Outcome after Embolic Stroke
Arch Neurol 48:1235-1238, Zivin,J.A.&Mazzarella,V., 1991
The Bioloigcal Basis for the Treatment of Acute Stroke
Neurol 41:1867-1873, Scheinberg,P., 1991
Wegener's Granulomatosis Mimicking Temporal Arteritis
Neurol 41:1694-1695, Palaic,M.,et al, 1991
Anti-Ri:An Antibody Associated with Paraneoplastic Opsoclonus and Breast Cancer
Ann Neurol 29:241-251, Luque,F.A.,et al, 1991
N-Methyl-D-Aspartate Antagonists in the Treatment of Parkinson's Disease
Arch Neurol 48:977-981, Greenamyre,J.T.&O'Brien,C.F., 1991
Diagnostic Value of Anti-Neuronal Antibodies for Paraneoplastic Disorders of the Nervous System
JNNP 53:940-943, Moll,J.W.B.,et al, 1990
The Spectrum of Neurologic Disease Associated with Anti-GM1 Antibodies
Neurol 40:1067-1072, Sadiq,S.A.,et al, 1990
Lower Motor Neuron Disease in a Patient with Autoantibodies Against Gangliosides GM1 and GD1b:Improvement with Immunotherapy
Neurol 40:842-844, Shy,M.E.,et al, 1990
Polyclonal IgM Anti-GM1 Ganglioside Antibody in Patients with Motor Neuron Disease and Variants
Ann Neurol 27:558-563, Salazar-Grueso,E.F.,et al, 1990
A Clinical Triad to Diagnose Paraneoplastic Retinopathy
Ann Neurol 28:162-167, Jacobson,D.M.,et al, 1990
Selective Expression of Purkinje-Cell Antigens in Tumor From Pts, with Paraneoplastic Cerbellar Degeneration
NEJM 322:1844-1851, Furneaux,H.M.,et al, 1990
Autoantibody Synthesis in the Central Nervous System of Patients with Paraneoplastic Syndromes
Neurol 40:1085-1091, Furneaux,H.F.,et al, 1990
Anti-GM1 IgM Antibodies in Motor Neuron Disease and Neuropathy
Neurol 40:1747-1750, Nobile-Orazio,E.,et al, 1990
The Remote Effects of Cancer on the Nervous System
in Neurol Manif of Systemic Dis, W. B. Saunders, Co, Phila, Neurologic Clinics 7:579-603, Dropcho,E.J., 1989
Cancer-Associated Retinopathy (Car Syndrome) with Antibodies Reacting with Retinal, Optic-Nerve, and Cancer Cells
NEJM 321:1589-1594, 1607-16081989., Thirkill,C.E.,et al, 1989
Antineural Autoantibodies in Patients with Paraneoplastic Cerebellar Degeneration
Arch Neurol 46:1225-1229, Tsukamoto,T.,et al, 1989
Anticerebellar Antibodies in Neurologically Normal Patients with Ovarian Neoplasm
Neurol 39:1605-1609, Brashear,H.R.,et al, 1989
Serum Antibodies to GM1 Ganglioside in Amytrophic Lateral Sclerosis
Neurol 38:1457-1461, Pestronk,A.,et al, 1988
An Antineuronal Autoantibody in Paraneoplastic Opsoclonus
Ann Neurol 23:528-531, Budde-Steffen,C.,et al, 1988
Autoantibody Activity in Lambert-Eaton Myasthenic Syndrome
Editorial, Lancet 1:9201988., , 1988
Treatment of Patients with Neuropathy and Anti-MAG IgM M-Proteins
Ann Neurol 24:93-97, Nobile-Orazio,E.,et al, 1988
Paraneoplastic Syndromes Involving the Eyes
In Walsh & Hoyt's Clin Neuro-ophthal, 4th ed, Williams & Wilkins, Vol 3, p 1735-1746, Miller,N.R., 1988
Central Nervous System Toxicity Associated With Metronidazole Therapy
Ann Int Med 93:59-60, Kusumi,R.K.,et al, 1980
Dominant Spinopontine Atrophy
Arch Neurol 35:156, Pogacar,S.,et al, 1978
Trypanosoma Cruzi in the Cerebrospinal Fluid During the Acute State of Chagas'Disease
NEJM 298:604, Hoff,R.,et al, 1978
Phenytoin-related Cerebellar Degeneration Without Seizures
II, et al, Ann Neurol 2:437977., Rapport,R.L., 1977
Phenytoin-induced Ophthalmoplegia
Neurol 26:1031, Spector,R.H.,et al, 1976
Diphenylhydantoin Intoxication & Cerebrospinal Fluid Protein
Neurol 18:1009-1011, Rawson,M.D., 1968
Neurological Disorders Associated with Adult Celiac Disease
Brain 89:683, Cooke,W.T.,et al, 1966
"Innumerable" lesion burden on brain MRI - a diagnostic approach
Diagnosis doi.org/10.1515/dx- 2025-2029, Finelli,P.F., 2025
Primary Central Nervous System Vasculitis with Thalamic Involvement
Neurol 104:e213665, Sarikaya,C.,et al, 2025
A 72-Year-Old Man With Meningoencephalitis
Neurol 104:e213658, Isaza-Pierotti,D.F.,et al, 2025
Clinicopathologic Conference, Cryptococcus Neoformans and Cushings Syndrome
NEJM 392:1847-1856, Case 13-2025, 2025
A 59-Year-Old Man with Progressive Dysarthria and Gait Instability
Neurol 104:e213729, Shen,D.,et al, 2025
Upadacitinib - An Up-and-Comer for Treatment of Giant-Cell Arteritis
NEJM 392:2062-2064, Koster,M.J. & Warrington,K.J., 2025
Rapidly Progressive Frontotemporal Dementia with Amytrophic Lateral Sclerosis in an Elderly Female
Cureus doi:10.7759/CUREUS.32182, Sweedan,Y.G.,et al, 2025
Clinicopathologic Conference, Posterior Reversible Encephalopathy Syndrome Due to Sickle Cell Disease
NEJM 392:268-276, Case 2-2025, 2025
Polka Dot Intracerebral Hemorrhage in Leukemia
Stroke 56:e49-e50, Rebchuk,A.D.,et al, 2025
Clinical Presentation, Investigation Findings, and Outcomes of IgG4-Related Pachymeningitis,A Systematic Review
JAMA Neurol 82:193-199, Terrim,S.,et al, 2025